AJP - Lung AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (November 14, 2008). doi:10.1152/ajplung.90376.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/2/L176    most recent
90376.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bentley, J K.
Right arrow Articles by Hershenson, M. B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bentley, J K.
Right arrow Articles by Hershenson, M. B
Submitted on July 8, 2008
Revised on October 21, 2008
Accepted on November 10, 2008

AIRWAY SMOOTH MUSCLE HYPERPLASIA AND HYPERTROPHY CORRELATE WITH GLYCOGEN SYNTHASE KINASE-3{beta} PHOSPHORYLATION IN A MOUSE MODEL OF ASTHMA

J Kelley Bentley1, Huan Deng1, Marisa J Linn1, Jing Lei1, Gregoriy A Dokshin1, Diane C. Fingar1, Khalil N. Bitar1, William R Henderson, Jr.2, and Marc B Hershenson1*

1 University of Michigan
2 University of Washington

* To whom correspondence should be addressed. E-mail: mhershen{at}umich.edu.

Increased airway smooth muscle (ASM) mass, a characteristic finding in asthma, may be caused by hyperplasia or hypertrophy. Cell growth requires increased translation of contractile apparatus mRNA, which is controlled in part by glycogen synthase kinase (GSK)-3{beta}, a constitutively-active kinase which inhibits eukaryotic initiation factor-2 activity and binding of methionyl tRNA to the ribosome. Phosphorylation of GSK-3{beta} inactivates it, enhancing translation. We sought to quantify the contributions of hyperplasia and hypertrophy to increased ASM mass in ovalbumin (OVA)-sensitized and -challenged Balb/c mice, and the role of GSK-3{beta} in this process. Immunofluorescent probes, confocal microscopy and stereological methods were used to analyze the number and volume of cells expressing {alpha}-smooth muscle actin and phospho-Ser9 GSK-3{beta} (pGSK). OVA treatment caused a 3-fold increase in ASM fractional unit volume or volume density (Vv) (PBS, 0.006±0.0003; OVA, 0.014±0.001), a 1.5-fold increase in ASM number per unit volume (Nv) and a 59% increase in volume per cell (Vv/Nv) (PBS, 824±76 µ3; OVA, 1310±183 µ3). In OVA-treated mice, there was a 12-fold increase in the Vv of pGSK (+) ASM, a 5-fold increase in the Nv of pGSK (+) ASM, and a 1.6 fold increase in Vv/Nv. Lung homogenates from OVA-treated mice showed increased GSK-3{beta} phosphorylation and lower GSK-3{beta} activity. Both hyperplasia and hypertrophy are responsible for increased ASM mass in OVA-treated mice. Phosphorylation and inactivation of GSK-3{beta} are associated with ASM hypertrophy, suggesting that this kinase may play a role in asthmatic airway remodeling.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.